MENU
+Compare
ZLAB
Stock ticker: NASDAQ
AS OF
Feb 21 closing price
Price
$33.78
Change
+$2.79 (+9.00%)
Capitalization
3.74B

ZLAB Zai Lab Limited Forecast, Technical & Fundamental Analysis

a service for cancer & autoimmune treatment

Industry Biotechnology
ZLAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ZLAB with price predictions
Feb 20, 2025

ZLAB in upward trend: price rose above 50-day moving average on January 27, 2025

ZLAB moved above its 50-day moving average on January 27, 2025 date and that indicates a change from a downward trend to an upward trend. In of 42 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 24, 2025. You may want to consider a long position or call options on ZLAB as a result. In of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ZLAB just turned positive on January 17, 2025. Looking at past instances where ZLAB's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for ZLAB crossed bullishly above the 50-day moving average on January 31, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ZLAB advanced for three days, in of 282 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 184 cases where ZLAB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 57 cases where ZLAB's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ZLAB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ZLAB broke above its upper Bollinger Band on February 13, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ZLAB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.513) is normal, around the industry mean (12.644). P/E Ratio (0.000) is within average values for comparable stocks, (84.748). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.591). ZLAB has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (9.259) is also within normal values, averaging (254.739).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZLAB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ZLAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ZLAB is expected to report earnings to rise 1,724.25% to -72 cents per share on February 27

Zai Lab Limited ZLAB Stock Earnings Reports
Q4'24
Est.
$-0.73
Q3'24
Beat
by $0.73
Q2'24
Missed
by $0.11
Q1'24
Beat
by $0.88
Q4'23
Missed
by $0.77
The last earnings report on November 12 showed earnings per share of -3 cents, beating the estimate of -76 cents. With 2.09M shares outstanding, the current market capitalization sits at 3.74B.
A.I. Advisor
published General Information

General Information

a service for cancer & autoimmune treatment

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
4560 Jinke Road
Phone
+86 2161632588
Employees
2175
Web
https://www.zailaboratory.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
COPLX191.84N/A
N/A
Copley Fund
IPSIX23.40N/A
N/A
Voya Index Plus SmallCap Port I
ASPYX33.17N/A
N/A
Alger Spectra Y
CSHCX9.29-0.03
-0.32%
NYLI Cushing® MLP Premier Class C
FUNFX84.90-0.49
-0.57%
American Funds Fundamental Invs F3

ZLAB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ZLAB has been loosely correlated with ONC. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ZLAB jumps, then ONC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZLAB
1D Price
Change %
ZLAB100%
+0.06%
ONC - ZLAB
42%
Loosely correlated
+3.17%
MDGL - ZLAB
38%
Loosely correlated
+2.15%
ADPT - ZLAB
34%
Loosely correlated
-0.48%
GOSS - ZLAB
33%
Loosely correlated
+7.75%
AMRN - ZLAB
33%
Loosely correlated
+0.49%
More